On this page
Dabur, Ferns N Petals and four others correct labels after FSSAI notices
Our read
FSSAI label crackdown broadens from pack corrections to online product claims, forcing FMCG brands and marketplaces into a compliance reset.
For operators
FSSAI’s notices show that food brands need immediate, end-to-end audits of packaging, listings, advertising and substantiation for health and product claims.
Watch
FSSAI disclosure of additional notice recipients, product categories or penalties.
The report,
FSSAI said six food businesses, including Dabur and Ferns N Petals, corrected misleading labels, packaging, marketing claims and advertisements after regulatory notices. Dabur reclassified an edible-oil listing as ayurvedic medicine, while Ferns N Petals updated chocolate labels.
Reported figures
From the report. Source details below
- 6 companies
- 100% label claims
Why it matters for the brand
For acquirers, misleading-claim exposure should be a core diligence item, including label inventories, regulatory correspondence and the cost of remediation across channels.
What to track next
- Formal product recalls, sales restrictions, prosecution notices or repeat-offender actions.
- Marketplace directives requiring verified labels or removal of non-compliant digital claims.
- A rise in consumer complaints, competitor challenges or advertising-regulator cases tied to food claims.
- Large FMCG companies announcing packaging redesigns, claim withdrawals or increased compliance provisions.
Likely next moves
Our read of what comes next — analysis, not reported by the source.
- Conduct a SKU-level audit of front-of-pack claims, ingredient statements, nutrition disclosures, category classification and mandatory declarations.
- Align packaging, advertising, D2C sites, quick-commerce listings, marketplace content and influencer briefs to a single approved claims library.
- Prioritize high-risk claims such as ayurvedic, medicinal, immunity, healthy, natural, sugar-free, protein-rich, preservative-free and therapeutic language.
- Build rapid pack-correction plans for printed inventory, including sticker overlays, phased sell-through and retailer communication.
- Require regulatory sign-off for marketing campaigns and establish evidence files substantiating every functional or health-related claim.
The counter-case
The case against this reading — not reported by the source.
Six corrective actions do not necessarily indicate broad-based FMCG compliance improvement; they may instead reveal that misleading claims and classification errors were already embedded in routine commercial practices. Dabur’s reported shift of an edible-oil listing to an ayurvedic-medicine category could raise questions about whether the correction resolves the underlying consumer-information issue or moves it into a different regulatory framework. For affected brands, label changes can create packaging write-offs, marketplace delistings, campaign disruption and reputational damage if consumers view prior claims as deceptive.